HUB
LIVE

Serial Number

79258264

Owner

HUB Organoids B.V. IP

Attorney

William C. Wright

Filing Date

Nov 29, 2018

Add to watchlist:

No watchlists yet
View on USPTO

HUB Trademark

Serial Number: 79258264 • Registration: 6050134

HUB is a trademark filed by HUB Organoids B.V. IP on November 29, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HUB Organoids B.V. IP (6 trademarks)

Yalelaan 62

Entity Type: 99

HUB Organoids IP B.V. (6 trademarks)

Yalelaan 62

Entity Type: 78

Stichting Hubrecht Organoid Technology (6 trademarks)

Yalelaan 62

Entity Type: 78

Trademark Details

Filing Date

November 29, 2018

Registration Date

May 12, 2020

Published for Opposition

February 25, 2020

Goods & Services

Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services

Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine, drug and vaccine testing services, namely, testing of pharmaceuticals; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine

Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes

Cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 28, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 28, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 28, 2025 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 12, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 7, 2024 ADCH
CHANGE OF OWNER RECEIVED FROM IB
Apr 5, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 15, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 15, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 12, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
May 12, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 22, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 5, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 5, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 22, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 22, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 22, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 22, 2020 CNEA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2020 NPUB
NOTIFICATION PROCESSED BY IB
Jan 17, 2020 GPNX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 14, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 6, 2020 PBCR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 1, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 1, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2020 NONP
ASSIGNED TO LIE
Dec 19, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 17, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 17, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 17, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 17, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 17, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2019 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Aug 1, 2019 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 8, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 8, 2019 REAP
REFUSAL PROCESSED BY IB
Jun 28, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 10, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 10, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 29, 2019 RFCR
NON-FINAL ACTION WRITTEN
May 28, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
May 14, 2019 MAFR
ASSIGNED TO EXAMINER
May 10, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 9, 2019 REPR